Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling
Clinical trial NCT00161278 · TERMINATED
Trial details
- NCT number
- NCT00161278
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2006-08-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.